1. OECD, The Organisation for Economic Co-operation and Development. Toward a New Comprehensive Global Database of Per- and Polyfluoroalkyl Substances (PFASs): Summary Report on Updating the OECD 2007 List of per and Polyfluoroalkyl Substances (PFASs)’. Retrieved 13 June 2019. 2018.
2. Poothong S, Papadopoulou E, Padilla-Sánchez JA, Thomsen C, Haug LS. Multiple pathways of human exposure to poly- and perfluoroalkyl substances (PFASs): From external exposure to human blood. Environment International. 2020;134:105244.
3. Frisbee SJ, Brooks AP, Maher A, Flensborg P, Arnold S, Fletcher T, et al. The C8 Health Project: Design, Methods, and Participants. Environmental Health Perspectives. 2009;117:1873–82.
4. Hölzer J, Midasch O, Rauchfuss K, Kraft M, Reupert R, Angerer J, et al. Biomonitoring of perfluorinated compounds in children and adults exposed to perfluorooctanoate-contaminated drinking water. Environ Health Perspect. 2008;116:651–7.
5. Li Y, Barregard L, Xu Y, Scott K, Pineda D, Lindh CH, et al. Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water. Environ Health. 2020;19:33.
6. Pitter G, Da Re F, Canova C, Barbieri G, Zare Jeddi M, Daprà F, et al. Serum Levels of Perfluoroalkyl Substances (PFAS) in Adolescents and Young Adults Exposed to Contaminated Drinking Water in the Veneto Region, Italy: A Cross-Sectional Study Based on a Health Surveillance Program. Environ Health Perspect. 2020;128:027007.
7. EFSA Panel on Contaminants in the Food Chain (CONTAM). Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food. 2018.
8. Zhou B, Bentham J, Di Cesare M, Bixby H, Danaei G, Cowan MJ, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. The Lancet. 2017;389:37–55.
9. Bao W-W, Qian Z, Geiger SD, Liu E, Liu Y, Wang S-Q, et al. Gender-specific associations between serum isomers of perfluoroalkyl substances and blood pressure among Chinese: Isomers of C8 Health Project in China. Science of The Total Environment. 2017;607–608:1304–12.
10. Khalil N, Ebert JR, Honda M, Lee M, Nahhas RW, Koskela A, et al. Perfluoroalkyl substances, bone density, and cardio-metabolic risk factors in obese 8–12 year old children: A pilot study. Environmental Research. 2018;160:314–21.
11. Ma S, Xu C, Ma J, Wang Z, Zhang Y, Shu Y, et al. Association between perfluoroalkyl substance concentrations and blood pressure in adolescents. Environmental Pollution. 2019;254:112971.
12. Min J-Y, Lee K-J, Park J-B, Min K-B. Perfluorooctanoic acid exposure is associated with elevated homocysteine and hypertension in US adults. Occup Environ Med. 2012;69:658–62.
13. Yang Q, Guo X, Sun P, Chen Y, Zhang W, Gao A. Association of serum levels of perfluoroalkyl substances (PFASs) with the metabolic syndrome (MetS) in Chinese male adults: A cross–sectional study. Science of The Total Environment. 2018;621:1542–9.
14. Chen A, Jandarov R, Zhou L, Calafat AM, Zhang G, Urbina EM, et al. Association of perfluoroalkyl substances exposure with cardiometabolic traits in an island population of the eastern Adriatic coast of Croatia. Science of The Total Environment. 2019;683:29–36.
15. Christensen KY, Raymond M, Thompson BA, Anderson HA. Perfluoroalkyl substances in older male anglers in Wisconsin. Environment International. 2016;91:312–8.
16. Donat-Vargas C, Bergdahl IA, Tornevi A, Wennberg M, Sommar J, Koponen J, et al. Associations between repeated measure of plasma perfluoroalkyl substances and cardiometabolic risk factors. Environment International. 2019;124:58–65.
17. Geiger SD, Xiao J, Ducatman A, Frisbee S, Innes K, Shankar A. The association between PFOA, PFOS and serum lipid levels in adolescents. Chemosphere. 2014;98:78–83.
18. He X, Liu Y, Xu B, Gu L, Tang W. PFOA is associated with diabetes and metabolic alteration in US men: National Health and Nutrition Examination Survey 2003–2012. Science of The Total Environment. 2018;625:566–74.
19. Liu H-S, Wen L-L, Chu P-L, Lin C-Y. Association among total serum isomers of perfluorinated chemicals, glucose homeostasis, lipid profiles, serum protein and metabolic syndrome in adults: NHANES, 2013–2014. Environmental Pollution. 2018;232:73–9.
20. Winquist A, Steenland K. Modeled PFOA Exposure and Coronary Artery Disease, Hypertension, and High Cholesterol in Community and Worker Cohorts. Environmental Health Perspectives. 2014;122:1299–305.
21. Lin P-ID, Cardenas A, Hauser R, Gold DR, Kleinman KP, Hivert M-F, et al. Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults—longitudinal analysis of the diabetes prevention program outcomes study. Environment International. 2019;129:343–53.
22. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018;39:3021–104.
23. Duchon J. Splines minimizing rotation-invariant semi-norms in Sobolev spaces. In: Schempp W, Zeller K, editors. Constructive Theory of Functions of Several Variables [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 1977 [cited 2020 Apr 10]. p. 85–100. Available from: http://link.springer.com/10.1007/BFb0086566
24. Wood, Simon. Mgcv: Mixed GAM Computation Vehicle with GCV/AIC/REML Smoothness Estimation.
25. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.
26. Hardy ST, Loehr LR, Butler KR, Chakladar S, Chang PP, Folsom AR, et al. Reducing the Blood Pressure–Related Burden of Cardiovascular Disease: Impact of Achievable Improvements in Blood Pressure Prevention and Control. JAHA [Internet]. 2015 [cited 2020 Jun 3];4. Available from: https://www.ahajournals.org/doi/10.1161/JAHA.115.002276
27. Sundström J, Neovius M, Tynelius P, Rasmussen F. Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts. BMJ. 2011;342:d643.
28. Huang M, Jiao J, Zhuang P, Chen X, Wang J, Zhang Y. Serum polyfluoroalkyl chemicals are associated with risk of cardiovascular diseases in national US population. Environment International. 2018;119:37–46.
29. Mastrantonio M, Bai E, Uccelli R, Cordiano V, Screpanti A, Crosignani P. Drinking water contamination from perfluoroalkyl substances (PFAS): an ecological mortality study in the Veneto Region, Italy. European Journal of Public Health. 2018;28:180–5.
30. Mattsson K, Rignell-Hydbom A, Holmberg S, Thelin A, Jönsson BA, Lindh CH, et al. Levels of perfluoroalkyl substances and risk of coronary heart disease: Findings from a population-based longitudinal study. Environmental Research. 2015;142:148–54.
31. Simpson C, Winquist A, Lally C, Steenland K. Relation between perfluorooctanoic acid exposure and strokes in a large cohort living near a chemical plant. Environmental Research. 2013;127:22–8.
32. Guzik TJ, Touyz RM. Oxidative Stress, Inflammation, and Vascular Aging in Hypertension. Hypertension. 2017;70:660–7.
33. Lin C-Y, Lee H-L, Hwang Y-T, Su T-C. The association between total serum isomers of per- and polyfluoroalkyl substances, lipid profiles, and the DNA oxidative/nitrative stress biomarkers in middle-aged Taiwanese adults. Environmental Research. 2020;182:109064.
34. Panaretakis T, Shabalina IG, Grandér D, Shoshan MC, DePierre JW. Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid. Toxicol Appl Pharmacol. 2001;173:56–64.
35. Wielsøe M, Long M, Ghisari M, Bonefeld-Jørgensen EC. Perfluoroalkylated substances (PFAS) affect oxidative stress biomarkers in vitro. Chemosphere. 2015;129:239–45.
36. Rodrigo R, González J, Paoletto F. The role of oxidative stress in the pathophysiology of hypertension. Hypertens Res. 2011;34:431–40.
37. Touyz RM, Rios FJ, Alves-Lopes R, Neves KB, Camargo LL, Montezano AC. Oxidative Stress: A Unifying Paradigm in Hypertension. Canadian Journal of Cardiology. 2020;36:659–70.
38. Rogers JM, Ellis-Hutchings RG, Grey BE, Zucker RM, Norwood J, Grace CE, et al. Elevated Blood Pressure in Offspring of Rats Exposed to Diverse Chemicals During Pregnancy. Toxicological Sciences. 2014;137:436–46.
39. Borghi C, Urso R, Cicero AF. Renin–angiotensin system at the crossroad of hypertension and hypercholesterolemia. Nutrition, Metabolism and Cardiovascular Diseases. 2017;27:115–20.
40. Kang JS, Choi J-S, Park J-W. Transcriptional changes in steroidogenesis by perfluoroalkyl acids (PFOA and PFOS) regulate the synthesis of sex hormones in H295R cells. Chemosphere. 2016;155:436–43.
41. Li Y, Fletcher T, Mucs D, Scott K, Lindh CH, Tallving P, et al. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water. Occupational and Environmental Medicine. 2018;75:46–51.
42. Stergiou GS, O’Brien E, Myers M, Palatini P, Parati G. STRIDE BP: an international initiative for accurate blood pressure measurement. Journal of Hypertension. 2020;38:395–9.